Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.80 |
| ▸ | MAPT | P10636 | 7/20 | 0.80 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.80 |
| ▸ | MAOA | P21397 | 4/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.80 |
| ▸ | HPGD | P15428 | 4/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.80 |
| ▸ | BCL2 | P10415 | 4/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.80 |
| ▸ | RECQL | P46063 | 3/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.80 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.80 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.80 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.80 |
| ▸ | TTR | P02766 | 2/20 | 0.80 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinalizarin SCHEMBL5709519 | 0.95 | MAPT (0.77) | MEN1KMT2AMAPTMCL1MAOA | |
| Purpurin SCHEMBL4970376 | 0.91 | MEN1 (0.96) | MEN1KMT2AMAPTMCL1MAOA | |
| Athraquinones A SCHEMBL4972786 | 0.89 | MAPT (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Athraquinones A SCHEMBL21114402 | 0.89 | MAPT (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Athraquinones A SCHEMBL29373337 | 0.89 | MAPT (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Athraquinones A SCHEMBL18614 | 0.89 | MAPT (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Purpurin SCHEMBL29429206 | 0.89 | MEN1 (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Purpurin SCHEMBL33871 | 0.89 | MEN1 (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Purpurin SCHEMBL29539242 | 0.89 | MEN1 (1.00) | MEN1KMT2AMAPTMCL1MAOA | |
| Athraquinones A SCHEMBL7839563 | 0.88 | MAPT (0.96) | MEN1KMT2AMAPTMCL1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107205980-B | Tissue and cell stain preparations with novel molecules obtained from corn poppy | M·布达克 | 2020-04-07 | — | — | CN | claimed |
| US-20170315031-A1 | TISSUE AND CELL STAIN FORMULA WITH A NOVEL MOLECULE OBTAINED FROM PAPAVER RHOEAS | BUDAK MEHMET (TR) | 2017-11-02 | — | — | US | claimed |
| EP-3209292-A1 | TISSUE AND CELL STAIN FORMULA WITH A NOVEL MOLECULE OBTAINED FROM PAPAVER RHOEAS | Budak, Mehmet (TR) | 2017-08-30 | — | — | EP | claimed |
| EP-1366196-A4 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE MEDICINE (US) | 2004-07-07 | — | — | EP | claimed |
| EP-1366196-A2 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE OF MEDICINE (US) | 2003-12-03 | — | — | EP | claimed |
| US-20030186237-A1 | Methods and compositions of amplifying RNA | BAYLOR COLLEGE OF MEDICINE | 2003-10-02 | — | — | US | claimed |
| WO-2002065093-A2 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE OF MEDICINE (US) | 2002-08-22 | — | — | WO | claimed |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | VENTANA MED SYST INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12496344-B2 | Biophotonic materials and uses thereof | FLE INT S R L (IT) | 2025-12-16 | — | — | US | disclosed |
| US-12474240-B2 | Stabilized two-part hematoxylin solution utilizing pH adjustment | VENTANA MEDICAL SYSTEMS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| CN-118078787-A | Pharmaceutical application of alizarin in preventing and treating aging and neurodegenerative diseases | 中国医学科学院药物研究所 | 2024-05-28 | — | — | CN | disclosed |
| US-11975221-B2 | Anti-microbial multilayer fabric media and method for making same | Shuai Danmeng (US) | 2024-05-07 | — | — | US | disclosed |
| US-11953493-B2 | Biophotonic methods for increasing in situ energy production and energy emission in biological cells and tissues | FLE INTERNATIONAL S.R.L. (IT) | 2024-04-09 | — | — | US | disclosed |
| WO-2007102146-A2 | METHODS AND COMPOSITIONS FOR IDENTIFYING A CELL PHENOTYPE | ZETIQ TECHNOLOGIES LTD. (IL) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007084429-A2 | BIOLOGICAL SAMPLE PROCESSING COMPOSITION AND METHOD | VENTANA MEDICAL SYSTEMS, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20070172911-A1 | Biological sample processing composition and method | VENTANA MEDICAL SYSTEMS, INC. | 2007-07-26 | — | — | US | disclosed |
| EP-1366196-A4 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE MEDICINE (US) | 2004-07-07 | — | — | EP | disclosed |
| EP-1366196-A2 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE OF MEDICINE (US) | 2003-12-03 | — | — | EP | disclosed |
| US-20030186237-A1 | Methods and compositions of amplifying RNA | BAYLOR COLLEGE OF MEDICINE | 2003-10-02 | — | — | US | disclosed |
| WO-2002065093-A2 | METHODS AND COMPOSITIONS OF AMPLIFYING RNA | BAYLOR COLLEGE OF MEDICINE (US) | 2002-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170315031-A1 | TISSUE AND CELL STAIN FORMULA WITH A NOVEL MOLECULE OBTAINED FROM PAPAVER RHOEAS | MYADM, PRSS8, MKI67 | MEN1 3419/4885KMT2A 910/4885MAPT 1972/4885 |
| US-20260043720-A1 | STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT | SMCHD1, KIT, CD68 | MEN1 53/4885KMT2A 897/4885MAPT 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.